OQS
XRAY icon

Occudo Quantitative Strategies’s Dentsply Sirona XRAY Stock Holding History

Occudo Quantitative Strategies’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-59,111
Closed -$676K – 953
2025
Q4 		$676K Buy
59,111
+40,767
+222% +$479K 0.05% 376
2025
Q3 		$233K Sell
18,344
-22,196
-55% -$322K 0.03% 550
2025
Q2 		$644K Sell
40,540
-46,206
-53% -$691K 0.07% 319
2025
Q1 		$1.3M Buy
+86,746
New +$1.54M 0.17% 172
2024
Q3 		– Sell
-26,300
Closed -$655K – 1049
2024
Q2 		$655K Sell
26,300
-2,386
-8% -$68.4K 0.12% 250
2024
Q1 		$952K Buy
+28,686
New +$980K 0.17% 170
2022
Q4 		– Sell
-240,137
Closed -$6.81M – 1430
2022
Q3 		$6.81M Buy
240,137
+173,320
+259% +$5.92M 0.53% 6
2022
Q2 		$2.39M Buy
66,817
+33,988
+104% +$1.37M 0.2% 140
2022
Q1 		$1.62M Buy
+32,829
New +$1.74M 0.14% 232

Other funds holding XRAY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Occudo Quantitative Strategies's XRAY Position: Q1 2026 in Review

Occudo Quantitative Strategies sold out of Dentsply Sirona (XRAY) in Q1 2026, closing a stake of 59,111 shares — an estimated $676K sold.

Occudo Quantitative Strategies first reported a position in XRAY in Q1 2022 and held it in 9 quarters. The position peaked at $6.81M in Q3 2022. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • Occudo Quantitative Strategies reported no remaining Dentsply Sirona position as of Q1 2026 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 59,111 Dentsply Sirona shares in Q1 2026, an estimated $676K.
  • Occudo Quantitative Strategies first reported a position in Dentsply Sirona in Q1 2022 and held it in 9 quarters.
  • Occudo Quantitative Strategies's Dentsply Sirona position peaked at $6.81M in Q3 2022.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.